Where Will ISRG Stock Be in 5 Years?
Intuitive Surgical (NASDAQ:ISRG) is the innovative medical tech business behind…
Buy
52
TLSA Quote, Financials, Valuation and Earnings
Last price:
$1.70
Seasonality move
:
8.1%
Day range:
$1.64 - $1.77
52-week range:
$0.63 - $2.60
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2,803.69x
P/B ratio:
65.31x
Volume:
448.9K
Avg. volume:
402.4K
1-year change:
112.09%
Market cap:
$213.8M
Revenue:
--
EPS (TTM):
-$0.13
Analysts' Opinion
-
Consensus RatingTiziana Life Sciences Ltd. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $8.01, Tiziana Life Sciences Ltd. has an estimated upside of 376.79% from its current price of $1.68.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $8.01 representing 100% downside risk from its current price of $1.68.
Fair Value
-
According to the consensus of 1 analyst, Tiziana Life Sciences Ltd. has 376.79% upside to fair value with a price target of $8.01 per share.
TLSA vs. S&P 500
-
Over the past 5 trading days, Tiziana Life Sciences Ltd. has overperformed the S&P 500 by 0.35% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Tiziana Life Sciences Ltd. does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Tiziana Life Sciences Ltd. has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Tiziana Life Sciences Ltd. reported revenues of --.
Earnings Growth
-
Tiziana Life Sciences Ltd. has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Tiziana Life Sciences Ltd. reported earnings per share of --.
Enterprise value:
253.3M
EV / Invested capital:
--
Price / LTM sales:
2,803.69x
EV / EBIT:
--
EV / Revenue:
3,030.01x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-163.97x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-01-27 | 2025-01-27 | 2025-01-27 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $57.3M | $32.3M | $15.2M | $7.8M | -- | |
| Total Assets | $58M | $35.1M | $17.4M | $11M | -- | |
| Current Liabilities | $8.8M | $5.3M | $3.9M | $9.1M | -- | |
| Total Liabilities | $9.2M | $5.3M | $4.1M | $9.1M | -- | |
| Total Equity | $48.8M | $29.8M | $13.3M | $1.9M | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-01-27 | 2025-01-27 | 2025-01-27 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
TLSA
Sector
Market Cap
$213.8M
$25.9M
Price % of 52-Week High
64.62%
51.6%
Dividend Yield
0%
0%
Shareholder Yield
--
-1.66%
1-Year Price Total Return
112.09%
-18.99%
Beta (5-Year)
0.024
0.485
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.61
200-day SMA
Buy
Level
$1.67
Bollinger Bands (100)
Sell
Level
1.56 - 1.96
Chaikin Money Flow
Sell
Level
-148.7K
20-day SMA
Buy
Level
$1.53
Relative Strength Index (RSI14)
Buy
Level
55.74
ADX Line
Buy
Level
8.15
Williams %R
Neutral
Level
-20
50-day SMA
Buy
Level
$1.62
MACD (12, 26)
Buy
Level
0.23
25-day Aroon Oscillator
Buy
Level
28
On Balance Volume
Neutral
Level
233.6K
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.4617)
Sell
CA Score
(Annual)
Level (-6.9156)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (9)
Sell
Ohlson Score
Level (10.2449)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Tiziana Life Sciences Ltd. is a clinical-stage biotechnology company, which engages in developing therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, Amyotrophic Lateral Sclerosis, and Alzheimer’s. The company was founded by Gabriele Marco Antonio Cerrone on February 11, 1998 and is headquartered in London, the United Kingdom.
Stock Forecast FAQ
In the current month, TLSA has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TLSA average analyst price target in the past 3 months is $8.01.
-
Where Will Tiziana Life Sciences Ltd. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Tiziana Life Sciences Ltd. share price will rise to $8.01 per share over the next 12 months.
-
What Do Analysts Say About Tiziana Life Sciences Ltd.?
Analysts are divided on their view about Tiziana Life Sciences Ltd. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Tiziana Life Sciences Ltd. is a Sell and believe this share price will drop from its current level to $8.01.
-
What Is Tiziana Life Sciences Ltd.'s Price Target?
The price target for Tiziana Life Sciences Ltd. over the next 1-year time period is forecast to be $8.01 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is TLSA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Tiziana Life Sciences Ltd. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of TLSA?
You can purchase shares of Tiziana Life Sciences Ltd. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Tiziana Life Sciences Ltd. shares.
-
What Is The Tiziana Life Sciences Ltd. Share Price Today?
Tiziana Life Sciences Ltd. was last trading at $1.70 per share. This represents the most recent stock quote for Tiziana Life Sciences Ltd.. Yesterday, Tiziana Life Sciences Ltd. closed at $1.68 per share.
-
How To Buy Tiziana Life Sciences Ltd. Stock Online?
In order to purchase Tiziana Life Sciences Ltd. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get TLSA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
TLSA
Sector
P/E ratio
--
23.82x
PEG ratio
--
-0.01x
P/B ratio
65.31x
1.83x
Price / LTM sales
2,803.69x
1.56x
Growth Metrics
TLSA
Sector
Revenue growth
--
4.18%
Earnings growth
--
9.66%
Revenue (5-year growth)
--
6.28%
Earnings forecast
--
-$0.18
Profitability
TLSA
Sector
Profitability FY 2024
-$124K
$3.1M
Return on invested capital
--
-32.89%
Return on assets
--
-29.56%
Return on equity
--
-38.66%
Earnings Date
Last Earnings Date
Sep
22
Next Earnings Date
Jan
27
Estimated Next Earnings Date
Apr
28
Balance Sheet
TLSA
Sector
Total cash
$1.1M
$25.2M
Short term investments
--
$25.1M
Total assets
$11.3M
$73M
Long term debt
--
$3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Kratos Stock a Good Investment?
UAV and hypersonic system defense contractor Kratos (NASDAQ:KTOS) has swung…
Is Palantir Stock Going to Crash?
AI and data analytics major Palantir (NASDAQ:PLTR) has become something…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
50
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
52
CVLT alert for Jan 27
Commvault Systems, Inc. [CVLT] is down 31.22% over the past day.
Buy
73
BNAI alert for Jan 27
Brand Engagement Network, Inc. [BNAI] is down 16.85% over the past day.
Buy
71
SANM alert for Jan 27
Sanmina Corp. [SANM] is down 21.58% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
